240 related articles for article (PubMed ID: 35370968)
1. Association of Age of Metabolic Syndrome Onset With Cardiovascular Diseases: The Kailuan Study.
Huang Z; Wang X; Ding X; Cai Z; Li W; Chen Z; Fang W; Cai Z; Lan Y; Chen G; Wu W; Chen Z; Wu S; Chen Y
Front Endocrinol (Lausanne); 2022; 13():857985. PubMed ID: 35370968
[TBL] [Abstract][Full Text] [Related]
2. Dynamic Changes of Metabolic Syndrome Alter the Risks of Cardiovascular Diseases and All-Cause Mortality: Evidence From a Prospective Cohort Study.
He D; Zhang X; Chen S; Dai C; Wu Q; Zhou Y; Jin Z; Wu S; Zhu Y
Front Cardiovasc Med; 2021; 8():706999. PubMed ID: 34422932
[No Abstract] [Full Text] [Related]
3. Associations of Type 2 Diabetes Onset Age With Cardiovascular Disease and Mortality: The Kailuan Study.
Zhao M; Song L; Sun L; Wang M; Wang C; Yao S; Li Y; Yun C; Zhang S; Sun Y; Hou Z; Wu S; Xue H
Diabetes Care; 2021 Jun; 44(6):1426-1432. PubMed ID: 35239970
[TBL] [Abstract][Full Text] [Related]
4. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
[TBL] [Abstract][Full Text] [Related]
5. Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan.
Lai YJ; Yen YF; Chen LJ; Hsu LF; Ahmadi MN; Inan-Eroglu E; Ku PW; Stamatakis E
Diabetes Metab; 2023 May; 49(3):101415. PubMed ID: 36563960
[TBL] [Abstract][Full Text] [Related]
6. Association of Age of Onset of Hypertension With Cardiovascular Diseases and Mortality.
Wang C; Yuan Y; Zheng M; Pan A; Wang M; Zhao M; Li Y; Yao S; Chen S; Wu S; Xue H
J Am Coll Cardiol; 2020 Jun; 75(23):2921-2930. PubMed ID: 32527401
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Syndrome Over 4 Years Before the Onset of Cardiovascular Disease - Nested Case-Control Study.
Hu H; Nakagawa T; Honda T; Yamamoto S; Nanri A; Konishi M; Okazaki H; Kuwahara K; Hori A; Nishiura C; Kashino I; Imai T; Nishihara A; Akter S; Miyamoto T; Sasaki N; Ogasawara T; Uehara A; Yamamoto M; Murakami T; Shimizu M; Eguchi M; Kochi T; Nagahama S; Tomita K; Kabe I; Mizoue T; Sone T; Dohi S;
Circ J; 2018 Jan; 82(2):430-436. PubMed ID: 28931789
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease.
Burger PM; Koudstaal S; Dorresteijn JAN; Savarese G; van der Meer MG; de Borst GJ; Mosterd A; Visseren FLJ;
Int J Cardiol; 2023 May; 379():66-75. PubMed ID: 36907452
[TBL] [Abstract][Full Text] [Related]
9. Association between metabolic syndrome severity score and cardiovascular disease: results from a longitudinal cohort study on Chinese adults.
Lin JJ; Dai PY; Zhang J; Guan YQ; Gong WW; Yu M; Fang L; Hu RY; He QF; Li N; Wang LX; Liang MB; Zhong JM
Front Endocrinol (Lausanne); 2024; 15():1341546. PubMed ID: 38654930
[TBL] [Abstract][Full Text] [Related]
10. Continuous metabolic syndrome severity score and the risk of CVD and all-cause mortality.
Tang X; Wu M; Wu S; Tian Y
Eur J Clin Invest; 2022 Sep; 52(9):e13817. PubMed ID: 35598176
[TBL] [Abstract][Full Text] [Related]
11. Association between metabolic syndrome and 10-year risk of developing cardiovascular disease in a Nigerian population.
Oguoma VM; Nwose EU; Skinner TC; Richards RS; Digban KA; Onyia IC
Int Health; 2016 Sep; 8(5):354-9. PubMed ID: 27118483
[TBL] [Abstract][Full Text] [Related]
12. Metabolic disorders increase the risk to incident cardiovascular disease in middle-aged and elderly Chinese.
Zhang ML; Hou XH; Zhu YX; Lu JX; Peng LP; Gu HL; Jia WP
Biomed Environ Sci; 2012 Feb; 25(1):38-45. PubMed ID: 22424625
[TBL] [Abstract][Full Text] [Related]
13. Exposure-weighted scoring for metabolic syndrome and the risk of myocardial infarction and stroke: a nationwide population-based study.
Lee EY; Han K; Kim DH; Park YM; Kwon HS; Yoon KH; Kim MK; Lee SH
Cardiovasc Diabetol; 2020 Sep; 19(1):153. PubMed ID: 32993664
[TBL] [Abstract][Full Text] [Related]
14. LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes.
Hoang K; Zhao Y; Gardin JM; Carnethon M; Mukamal K; Yanez D; Wong ND
JACC Cardiovasc Imaging; 2015 Sep; 8(9):1007-1015. PubMed ID: 26319502
[TBL] [Abstract][Full Text] [Related]
15. High-Risk Human Papillomavirus Infection and the Risk of Cardiovascular Disease in Korean Women.
Joo EJ; Chang Y; Kwon MJ; Cho A; Cheong HS; Ryu S
Circ Res; 2019 Mar; 124(5):747-756. PubMed ID: 30727837
[TBL] [Abstract][Full Text] [Related]
16. Association between remnant cholesterol, metabolic syndrome, and cardiovascular disease: post hoc analysis of a prospective national cohort study.
Jin J; Hu X; Francois M; Zeng P; Wang W; Yu B; Zhou Y; Dong H
Eur J Med Res; 2023 Oct; 28(1):420. PubMed ID: 37821969
[TBL] [Abstract][Full Text] [Related]
17. The impact of the metabolic score for insulin resistance on cardiovascular disease: a 10-year follow-up cohort study.
Wu Z; Cui H; Zhang Y; Liu L; Zhang W; Xiong W; Lu F; Peng J; Yang J
J Endocrinol Invest; 2023 Mar; 46(3):523-533. PubMed ID: 36125732
[TBL] [Abstract][Full Text] [Related]
18. Association of metabolic syndrome with risk of cardiovascular disease mortality and all-cause mortality among Malaysian adults: a retrospective cohort study.
Chee Cheong K; Lim KH; Ghazali SM; Teh CH; Cheah YK; Baharudin A; Lim HL; Abdul Hamid AM; Mustapha FI; Omar MA
BMJ Open; 2021 Aug; 11(8):e047849. PubMed ID: 34408040
[TBL] [Abstract][Full Text] [Related]
19. Added value of different metabolic syndrome definitions for predicting cardiovascular disease and mortality events among elderly population: Tehran Lipid and Glucose Study.
Mozaffary A; Bozorgmanesh M; Sheikholeslami F; Azizi F; Eskandari F; Hadaegh F
Eur J Clin Nutr; 2014 Jul; 68(7):853-8. PubMed ID: 24865481
[TBL] [Abstract][Full Text] [Related]
20. Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex.
Matsubayashi Y; Fujihara K; Yamada-Harada M; Mitsuma Y; Sato T; Yaguchi Y; Osawa T; Yamamoto M; Kitazawa M; Yamada T; Kodama S; Sone H
Cardiovasc Diabetol; 2022 Jun; 21(1):90. PubMed ID: 35655263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
